// App-Quantinova.ai

e15048 : A phase I study of temsirolimus as novel therapeutic drug for patients with unresectable hepatocellular carcinoma (HCC).

Researchers

Presenter

  • Stephen Lam Chan

Principal Investigators

  • Frankie Mo

  • Edwin P. Hui

  • Simon Yu

  • Anthony T. C. Chan

  • Winnie Yeo

  • Jane Koh

  • CM Chu

  • Joyce Hui

  • Leung Li

  • Herbert H. Loong

  • Wing Ming Ho

  • Brigette Ma

  • Ka Fai To

Medical Centers

  • Department of Imaging and Interventional Radiology, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China

  • Department of Imaging and Interventional Radiology, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China

  • Department of Clinical Oncology, State Key Laboratory of Oncology in South China, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, China

  • Department of Imaging and Interventional Radiology, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, China

  • Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong

  • The Chinese University of Hong Kong, Prince of Wales Hospital, Sha Tin, Hong Kong

  • Sir YK Pao Center for Cancer, State Key Laboratory in Oncology in South China, Department of Clinical Oncology, The Chinese University of Hong Kong, Shatin, Hong Kong

  • Prince of Wales Hospital, Shatin, Hong Kong

  • Sir YK Pao Center for Cancer, State Key Laboratory in Oncology in South China, Department of Clinical Oncology, The Chinese University of Hong Kong, Shatin, Hong Kong

  • Department of Diagnostic Imaging and Interventional Radiology, The Chinese University of Hong Kong , Shatin , Hong Kong

  • Department of Clinical Oncology, The University of Hong Kong, Hong Kong, Hong Kong

Locations

  • China

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Temsirolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT00321594

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved